C

CorMedix
D

CRMD

14.340
USD
-0.20
(-1.38%)
مغلق
حجم التداول
39,433
الربح لكل سهم
1
العائد الربحي
-
P/E
57
حجم السوق
972,605,610
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ 8 أشهر
buy
2024-10-03 07:52
CRMD Chart
المزيد
أصول ذات صلة
A
AGEN
0.44600
(9.51%)
5.13600 USD
A
AKBA
0.03500
(0.98%)
3.59000 USD
C
CLRB
-0.03150
(-7.64%)
0.38080 USD
D
DVAX
-0.100
(-0.97%)
10.165 USD
M
MDGL
-10.97
(-3.71%)
284.82 USD
R
RDHL
0.02000
(1.14%)
1.78000 USD
R
RMTI
0.01470
(1.56%)
0.95650 USD
S
SNDX
-0.25000
(-2.44%)
9.99000 USD
المزيد
الأخبار المقالات

العنوان: CorMedix

القطاع: Healthcare
الصناعة: Biotechnology
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.